Puneet Singh, Doreen Agnese, Miral Amin, Andrea V Barrio, Astrid Botty Van den Bruele, Erin Burke, David N Danforth, Frederick M Dirbas, Firas Eladoumikdachi, Olga Kantor, Shicha Kumar, Marie Catherine Lee, Cindy Matsen, Toan T Nguyen, Tolga Ozmen, Ko Un Park, Jennifer K Plichta, Chantal Reyna, Shayna L Showalter, Toncred Styblo, Nicholas Tranakas, Anna Weiss, Christine Laronga, Judy Boughey
Rates of contralateral mastectomy (CM) among patients with unilateral breast cancer have been increasing in the United States. In this Society of Surgical Oncology position statement, we review the literature addressing the indications, risks, and benefits of CM since the society's 2017 statement. We held a virtual meeting to outline key topics and then conducted a literature search using PubMed to identify relevant articles. We reviewed the articles and made recommendations based on group consensus. Patients consider CM for many reasons, including concerns regarding the risk of contralateral breast cancer (CBC), desire for improved cosmesis and symmetry, and preferences to avoid ongoing screening, whereas surgeons primarily consider CBC risk when making a recommendation for CM...
April 2024: Annals of Surgical Oncology